| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |